These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8441235)

  • 1. Effects of kidney or kidney-pancreas transplantation on plasma pentosidine.
    Hricik DE; Schulak JA; Sell DR; Fogarty JF; Monnier VM
    Kidney Int; 1993 Feb; 43(2):398-403. PubMed ID: 8441235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation.
    Hricik DE; Wu YC; Schulak A; Friedlander MA
    Clin Transplant; 1996 Dec; 10(6 Pt 1):568-73. PubMed ID: 8996781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease.
    Friedlander MA; Wu YC; Schulak JA; Monnier VM; Hricik DE
    Am J Kidney Dis; 1995 Mar; 25(3):445-51. PubMed ID: 7872323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine.
    Miyata T; Ueda Y; Shinzato T; Iida Y; Tanaka S; Kurokawa K; van Ypersele de Strihou C; Maeda K
    J Am Soc Nephrol; 1996 Aug; 7(8):1198-206. PubMed ID: 8866413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentosidine and its deposition in renal tissue in renal transplantation.
    Yoshida K; Yoneda T; Fujimoto K; Hirao Y; Konishi N
    Transplant Proc; 2005 Dec; 37(10):4266-72. PubMed ID: 16387094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
    Sugiyama S; Miyata T; Ueda Y; Tanaka H; Maeda K; Kawashima S; Van Ypersele de Strihou C; Kurokawa K
    J Am Soc Nephrol; 1998 Sep; 9(9):1681-8. PubMed ID: 9727377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduction of carbonyl stress with renal replacement therapy in chronic renal failure].
    Słowik-Zyłka D
    Ann Acad Med Stetin; 2004; 50(2):5-15. PubMed ID: 16529161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma pentosidine levels in uremic patients before and after hemodialysis.
    Takahashi M; Kushida K; Ishihara C; Denda M; Inoue T
    Scand J Urol Nephrol; 1995 Jun; 29(2):131-4. PubMed ID: 7569788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products in children with chronic renal failure and type 1 diabetes.
    Misselwitz J; Franke S; Kauf E; John U; Stein G
    Pediatr Nephrol; 2002 May; 17(5):316-21. PubMed ID: 12042886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of plasma pentosidine concentrations with renal function in kidney graft recipients.
    Slowik-Zylka D; Safranow K; Dziedziejko V; Ciechanowski K; Chlubek D
    Clin Transplant; 2010; 24(6):839-47. PubMed ID: 20030678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
    Franke S; Müller A; Sommer M; Busch M; Kientsch-Engel R; Stein G
    Clin Nephrol; 2003 Feb; 59(2):88-97. PubMed ID: 12608551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
    Hirata K; Kubo K
    Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered kidney graft high-energy phosphate metabolism in kidney-transplanted end-stage renal disease type 1 diabetic patients: a cross-sectional analysis of the effect of kidney alone and kidney-pancreas transplantation.
    Fiorina P; Perseghin G; De Cobelli F; Gremizzi C; Petrelli A; Monti L; Maffi P; Luzi L; Secchi A; Del Maschio A
    Diabetes Care; 2007 Mar; 30(3):597-603. PubMed ID: 17327327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily haemodialysis improves indices of protein glycation.
    Floridi A; Antolini F; Galli F; Fagugli RM; Floridi E; Buoncristiani U
    Nephrol Dial Transplant; 2002 May; 17(5):871-8. PubMed ID: 11981076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy.
    Miyata T; Ueda Y; Yoshida A; Sugiyama S; Iida Y; Jadoul M; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Mar; 51(3):880-7. PubMed ID: 9067925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure.
    Sanaka T; Funaki T; Tanaka T; Hoshi S; Niwayama J; Taitoh T; Nishimura H; Higuchi C
    Nephron; 2002 May; 91(1):64-73. PubMed ID: 12021521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy.
    Raj DS; Lim G; Levi M; Qualls C; Jain SK
    Am J Kidney Dis; 2004 Jan; 43(1):154-60. PubMed ID: 14712439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous pancreas-kidney transplantation in Hispanic recipients with type I diabetes mellitus and end-stage renal disease.
    Ciancio G; Burke GW; Gomez C; Olson L; Esquenazi V; Miller J
    Transplant Proc; 1997 Dec; 29(8):3717. PubMed ID: 9414898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.